The Inspire Sleep Apnea Implant is really a medical device that is implanted in to the body for the treatment of snoring and obstructive sleep apnea (OSA) syndrome.
Obstructive ANTI SNORING Syndrome
Obstructive sleep apnea syndrome is a disease due to relapsing episodes of sleep apnea. This can be a condition where breathing stops for more than 10 seconds, during which oxygen saturation in the blood is reduced by a lot more than 4%.
OSA syndrome occurs while asleep, when the muscles of upper airways relax, causing the obstruction of the respiratory system. This leads to deterioration of blood oxygenation and provokes short unconscious wake-up episodes through the entire night. An unhealthy pattern of sleep places stress on the body, causing increased blood circulation pressure and development of severe diseases. The diseases due to OSA can be physical, such as for example hypertension, myocardium infarction and stroke. They could also be mental, including depression, chronic fatigue syndrome, loss of memory and concentration.
Before any treatment, a sleep study or a polysomnography is necessary. The polysomnography calculates the apnea index, which is the frequency of apnea episodes during 1 hour of sleep and determines the severe nature of the condition. The apnea index is known as significant if there are a lot more than 20 apnea episodes per hour, regardless of the presence or absence of clinical symptoms.
The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy isn’t for everyone as many people find it uncomfortable to sleep with the mask on the facial skin and the device itself could be loud, especially since it commonly sits close to the head. Only 25% of patients may use CPAP-therapy for a long period of time.
Therefore, recently Inspire Medical Systems Inc. has come up with a very effective solution with the Inspire Sleep Apnea Implant.
How The Inspire ANTI SNORING Implant Works
The Inspire Sleep Apnea Implant is a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately a decade.
The main unit of this device is placed under the skin, on leading right side of the chest and it monitors the phase of breathing. The other electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens the upper airways and allows the tongue to stand out, and helps keep the airways open while asleep.
As well as the two electrodes, this product also includes a handy small remote switch, that actually turns on the device before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating during the active phase of the day, whenever a person needs physiological narrowing of the larynx and tongue movements for these processes.
The individual may feel light involuntary contractions of the larynx, or tongue movements during initial use of these devices. These movements do not cause pain, instead just a minor discomfort. These unpleasant effects disappear after the first few uses of the device.
Generally, the implant should be checked one or two 2 times each year. However, with regards to the situation, an Inspire therapy-trained doctor may consult patients pretty much often.
The Inspire Sleep Apnea Implant is only suitable for:
Patients who are more than 22 years old.
Patients who have been identified as having moderate or severe obstructive sleep apnea syndrome.
Patients having an apnea index in the range of 20 to 65.
Patients who are not comfortable with using CPAP therapy or didn’t work.
Patients with a body mass index of less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
An individual with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire ANTI SNORING Implant may potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive anti snoring syndrome. A study by Dr. Ryan J. et al. has shown that after implantation of the Inspire ANTI SNORING Implant, snoring is greatly decreased. A share of “no” or “soft” snoring changed from 22% at beginning of the treatment to 88% at 12 months and 91% at 24 months after the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the analysis reported a nightly usage of this therapy for five years. ufabet Therefore, it really is evident that this method is impressive and easy to use!